Epigenetic Effects Elicited By Lactobacillus GG In Children With Cow's Milk Allergy
NCT02062476 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2014-02-13
Summary
Lactobacillus GG (LGG) is able to exert long lasting effects in children with atopic disorders. We have shown that Nutramigen LGG accelerates tolerance acquisition in infants with cow's milk allergy (CMA). The mechanisms of these effects are still largely undefined. The effect of LGG could be related at least in part by the immunoregulatory role played by LGG. This probiotic can balance the generation of cytokines possibly involved in IgE- or non-IgE-mediated CMA (i.e., IL-4, IL-5, IL-10, IFN-γ , TGF-beta, and TNF-alfa), which can contribute to modulation of inflammatory processes. We have demonstrated that children with IgE-mediated CMA produce significantly higher level of IL-4 and IL-13 in response to cow's milk protein, and that tolerance is associated with a marked reduction of IL-13 production and a concomitant increased frequency of IFN-γ releasing cells.
Epigenetics studies the heritable (and potentially reversible) changes of the genome inherited from one cell generation to the next which alter gene expression but do not involve changes in primary DNA sequences, highlighting the complexity of the inter-relationship between genetics and nutrition. There are three distinct, but closely interacting, epigenetic mechanisms (histone acetylation, DNA methylation, and non-coding microRNAs) that are responsible for modifying the expression of critical genes associated with physiologic and pathologic processes. The profile of epigenetic modifications associated with Th lineage commitment, coupled with the sensitivity of the early developmental period, has led to speculation that factors that disrupt these pathways may increase the risk of allergic diseases. Specifically, effects on DNA methylation and endogenous histone deacetylase inhibitors acting on specific pathways (Th1 and T regulatory cell differentiation) may favour Th2-associated allergic differentiation. MicroRNAs are another structural components of an epigenetic mechanism of post-transcriptional regulation of messenger RNA translation. It has been recently identified a specific Th2-associated miRNA (miR-21) that is critical for the regulation of Th cell polarization.
Conditions
- Cow's Milk Allergy
Interventions
- DIETARY_SUPPLEMENT
-
Lactobacillus GG
Sponsors & Collaborators
-
Federico II University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 4 Months
- Max Age
- 48 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-07-31
- Primary Completion
- 2014-08-31
Countries
- Italy
Study Locations
More Related Trials
-
Effect of a Probiotic on Grass Pollen Allergic Rhinitis Subjects
NCT01150253 ·Status: COMPLETED ·Phase: NA
-
Influence of Probiotics on Prevention of Atopy, Atopic Disease and Immunological Responses
NCT00318695 ·Status: COMPLETED ·Phase: PHASE2
-
Primary Prevention of Allergic Disease in Early Child by Lactobacillus Reuteri
NCT01285830 ·Status: COMPLETED ·Phase: PHASE2
-
Impact in Off-spring of Mothers After Perinatal Daily Intake of a Probiotic
NCT00159523 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Lactobacillus GG (LGG) in Children With Abdominal Pain
NCT00876291 ·Status: COMPLETED ·Phase: NA
-
The Effects of Probiotics, Lactobacillus GG, in the Treatment of Abdominal Pain in Children With Functional Abdominal Pain Disorders
NCT06310733 ·Status: RECRUITING ·Phase: PHASE4
-
Probiotics and Allergic Diseases
NCT01635738 ·Status: COMPLETED ·Phase: NA
-
Randomized Placebo-controlled Study of L. Reuteri NCIMB 30351 in GI Functional Disorders and Food Allergy in Newborns
NCT04262648 ·Status: COMPLETED ·Phase: NA
-
Effect of a L. Paracasei Strain on Grass Pollen Allergic Rhinitis Subjects
NCT01233154 ·Status: COMPLETED ·Phase: NA
-
Administration of a Lactobacillus GG and Vitamins Containing Mixture is Effective in Preventing Nosocomial Infection in Children
NCT02558192 ·Status: COMPLETED ·Phase: PHASE3
-
Prevention of the Minor Digestive Disorders by Lactobacillus Reuteri Supplementation
NCT01235884 ·Status: COMPLETED ·Phase: NA
-
Preventive Effect of Cow's Milk Fermented With Lactobacillus Paracasei CBA L74 on Common Infectious Diseases in Children
NCT05484102 ·Status: COMPLETED ·Phase: NA
-
Prevention of Necrotizing Enterocolitis of Premature Newborns Under Less Than 1500 g Using Probiotics
NCT02245815 ·Status: COMPLETED ·Phase: NA
-
The Anti-allergic Effects of Specific Probiotics
NCT00480129 ·Status: COMPLETED ·Phase: PHASE1
-
Lacticaseibacillus Rhamnosus LRa05 for Alleviating Allergic Rhinitis in Children
NCT06699537 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Safety of Lactobacillus Rhamnosus GG ATCC 53103 (LGG) in Healthy Volunteers
NCT00934453 ·Status: COMPLETED ·Phase: PHASE1
-
Effect and Tolerability of Lactobacillus Rhamnosus GG LA801 for the Preventive Nutritional Care of Nosocomial Diarrhea in Children
NCT04628819 ·Status: TERMINATED ·Phase: NA
-
Effect of Probiotics in Reducing Infections and Allergies in Young Children Starting Daycare
NCT02180581 ·Status: COMPLETED ·Phase: NA
-
Efficacy of a New Symbiotic Formulation in Children With Familial Hypercholesterolemia
NCT02048410 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of a Mixture of New Probiotic Strains in Preterm Infants
NCT03701906 ·Status: COMPLETED ·Phase: NA
-
Influence of Probiotics on Atopy With Focus on Respiratory Allergic Diseases- Follow-up to 7 Years
NCT00826189 ·Status: COMPLETED
-
Combined Lactobacilli (Reuteri LMG P-27481 and GG ATCC 53103) to Prevent Antibiotic Associated Symptoms in Children
NCT04836013 ·Status: UNKNOWN ·Phase: NA
-
Probiotics For The Prevention of Antibiotics Associated Diarrhea in the Pediatric Intensive Care Unit
NCT06109740 ·Status: COMPLETED ·Phase: NA
-
Does Daily Supplementation of Lactobacillus Acidophilus MPH734, for One Week, Affect Acute (Immediate), Subacute (7 Days), and Post-treatment Discontinuation Lactose Metabolism, Gastrointestinal Symptoms, and Clinical Markers of Inflammation and Safety Compared to a Placebo
NCT04531033 ·Status: COMPLETED ·Phase: NA
-
Use of a Probiotic Supplement to Prevent Asthma in Infants
NCT00113659 ·Status: COMPLETED ·Phase: NA